Reliis has a clear vision of creating innovative solutions by leveraging safe and effective medicines to address unmet clinical needs, with significant commercial value.

What sets Reliis apart is its strong emphasis on collaboration with renowned medical professionals and clinicians. This distinctive approach, combined with a highly dedicated and knowledgeable team, has established Reliis as an emerging player in the industry.

One of Reliis' key strategies is drug reformulation, which enables a faster and more cost-effective pathway for regulatory approval and commercialisation compared to traditional novel drug development programs.

To ensure the highest level of expertise and insight, Reliis maintains an esteemed Scientific Advisory Board composed of members who actively engage and collaborate with various stakeholders, including medical professionals, researchers, and pharmaceutical experts. By drawing from their practical experience with patients, Reliis' specialist clinicians can identify drugs that enhance patient care and target unmet medical needs.

Currently, Reliis has a robust product pipeline consisting of several high-priority drugs and a medical device. These initiatives highlight Reliis' commitment to advancing healthcare through innovation and addressing critical challenges in patient treatment and care.

Reliis

Org chart

Teams

Offices